← Leaderboards
Kelly Hubert
University Of Iowa
$162,164
Attributed
$162,164
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50.5K · FY2017–20$100K$75K$50K$25K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$162,164 · 1
By mechanism
F30$162,164 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Joseph J Cullen$5,964,157
- Barry London$19,559,318
- Bryan Allen$2,697,856
- Daniel Ellis Hyer$3,141,821
- Bing Li$13,995,652
Others in their field
Other Emerging Leaders on “Adjuvant”
- Ted Ross · University Of Georgia$68,763,143
- Jay Evans · University Of Montana$43,101,450
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Aaron Esser-Kahn · University Of Chicago$13,698,058
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$10,000,000
- Garcia-Sastre Adolfo · Icahn School Of Medicine At Mount Sinai$8,560,974
Research focus
AdjuvantAldehyde Dehydrogenase 1AlcoholismBasic ScienceBiochemicalBiologyBreastBreast Cancer CellBreast Cancer PatientCancer CellCancer Stem CellCancer TherapyCancer TypeCarboplatinCd44 GeneCell KillingCell RespirationCellsCell SurvivalCessation Of LifeChemosensitizationChemotherapyCombined Cancer Modality TherapyCopper
Grant awards (4)
Targeting lung and breast cancer cell oxidative metabolism with D-penicillamine and disulfiram$50,520
F30 · FY2020 · CA · contact PI
Targeting lung and breast cancer cell oxidative metabolism with D-penicillamine and disulfiram$42,940
F30 · FY2019 · CA · contact PI
Targeting lung and breast cancer cell oxidative metabolism with D-penicillamine and disulfiram$34,592
F30 · FY2018 · CA · contact PI
Targeting lung and breast cancer cell oxidative metabolism with D-penicillamine and disulfiram$34,112
F30 · FY2017 · CA · contact PI